Skip to content
PeptideAgent

Telehealth providers in North Carolina

By the PeptideAgent Editorial Team. Draft, pending editorial review.  Last verified

Telehealth prescribing is allowed in North Carolina. What North Carolina requires of telehealth prescribers and pharmacies, plus verified listings.

North Carolina at a glance

503A framework
Follows the federal 503A framework
Telehealth prescribing
Regulatory: Telehealth allowed
Asynchronous prescribing
Regulatory: Async unclear
Compounded GLP-1 access
Regulatory: Compounded GLP-1 limited

Verified telehealth providers serving North Carolina

No verified telehealth providers serving North Carolina are listed yet. A provider appears here only after it passes the verification checklist, and those checks are still under way.

Looking for care now? Start with what the law allows where you live, then how a legitimate prescription works.

Run a pharmacy, clinic, or telehealth service? Apply for a listing.

Telehealth prescribing rules in North Carolina

North Carolina regulates telemedicine prescribing mainly through North Carolina Medical Board Position Statement 5.1.4 (Telemedicine) rather than a practice statute. The Board's position is that an evaluation need not be in person if the licensee uses technology sufficient to accurately diagnose and treat the patient in conformity with the standard of care, that licensees prescribing by telemedicine must follow state and federal law, and that some circumstances, such as treating chronic pain with controlled substances, are not suitable for telemedicine-only care. The prescriber must hold a North Carolina license. The position statement does not approve questionnaire-only prescribing, so this record leaves asynchronous prescribing unconfirmed. None of the peptides in this database are controlled substances. [2]

Compounded GLP-1 access in North Carolina

Any out-of-state pharmacy shipping compounded GLP-1s in must hold an annual G.S. 90-85.21A registration. [3] [5] [9]

Research use only sellers in North Carolina

The North Carolina Food, Drug, and Cosmetic Act (G.S. 106-120 and following) prohibits selling adulterated or misbranded drugs, and the Pharmacy Practice Act restricts dispensing of legend drugs to permitted pharmacies. [4] [7] [10]

How to check a telehealth provider in North Carolina

  1. Confirm the prescriber is licensed or registered to treat patients located in North Carolina; the telehealth rules above explain what North Carolina requires. [2]
  2. Ask which pharmacy will fill the prescription and check it in the North Carolina Board of Pharmacy license lookup. [1] [3] [4] [5] [6] [8]
  3. Get the full price in writing first: consult fees, membership fees, and the medication itself.
  4. Walk away from any seller that labels a peptide "research use only" or "not for human consumption". See the research use only section above for what that means in North Carolina. [4] [7] [10]

Common questions in North Carolina

Does North Carolina have a telehealth statute?

Not a general practice statute. North Carolina relies on the Medical Board's telemedicine position statement and general licensing law, so the standard of care governs what evaluation is needed before prescribing. [2]

Can an out-of-state pharmacy ship compounded peptides to me in North Carolina?

Only if it registers annually with the North Carolina Board of Pharmacy under G.S. 90-85.21A. The Board can refuse registration to pharmacies disciplined at home for compounding violations. [1] [3]

All peptide legal questions for North Carolina

Sources

  1. [1]North Carolina Board of Pharmacy
  2. [2]North Carolina Medical Board Position Statement 5.1.4, Telemedicine
  3. [3]N.C. G.S. 90-85.21A, Pharmacies outside North Carolina (nonresident registration)
  4. [4]N.C. G.S. Chapter 90, Article 4A, North Carolina Pharmacy Practice Act
  5. [5]North Carolina Board of Pharmacy newsletter, July 2023 (semaglutide compounding)
  6. [6]North Carolina Board of Pharmacy: General pharmacy FAQs (compounding GLP-1s and semaglutide)
  7. [7]N.C. G.S. Chapter 106, Article 12, Food, Drug, and Cosmetic Act
  8. [8]FDA: Section 503A of the Federal Food, Drug, and Cosmetic ActFDA
  9. [9]FDA: concerns with unapproved GLP-1 drugs used for weight loss, including shortage resolution and compounding grace periodsFDA
  10. [10]21 U.S.C. 331, Prohibited acts